US2021233656A1PendingUtilityA1
Health management
Est. expiryDec 15, 2039(~13.4 yrs left)· nominal 20-yr term from priority
G06Q 10/40G06N 3/045G06N 7/01G06N 3/0495G06N 3/09G06N 3/094G06N 3/098G06N 3/0464G06N 3/0475G06N 3/08A61B 5/0205A61B 5/7267G16H 50/30A61B 5/021G16H 40/67G16H 20/30A61B 5/14532A61B 5/486G16H 50/50G16H 20/60A61B 5/7275A61B 5/0537G16H 10/60A61B 5/1118G16H 50/20G16H 40/63G06N 3/04A61B 5/4866A61B 5/4836G06Q 50/01G06Q 10/42
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method includes capturing continuously vital signs and motion data from one or more sensors adapted to be coupled to a user; capturing food consumption of the user; predicting a predetermined health condition of the user based on the vital signs; generating a plan for the predetermined health condition; and prompting the user to execute the plan with a closed-loop feedback based on sensor data.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method, comprising:
characterizing a personalized glucose prediction for a plurality of food types for a user; capturing vital signs and motion data including one or more non-invasive glucose, vital sign and motion sensors adapted to be coupled to a user; predicting a predetermined health condition of the user based on the personalized user glucose prediction, vital sign, and motion data detected by the wearable device; generating a plan to control user glucose by for controlling diet and physical activity with feedback from the vital sign, motion data and glucose level; and prompting the user with the wearable device to execute the plan.
2 . A method, comprising:
capturing vital signs and motion data from a wearable device including one or more blood pressure, vital sign and motion sensors adapted to be coupled to a user; performing non-invasive sensing using the wearable device to detect blood pressure level; predicting a predetermined health condition of the user based on the vital signs and motion data collected by the wearable device; generating a plan with the mobile device including addressing the predetermined health condition of blood pressure by controlling physical activity with feedback from the vital signs, motion data and blood pressure level; and prompting the user to execute the plan.
3 . The method of claim 1 , comprising determining an effect of a predetermined food item on glucose.
4 . The method of claim 3 , comprising determining an effect of a second food item on glucose when taken with the predetermined food item.
5 . The method of claim 1 , comprising prompting the user with the mobile device to perform a physical activity within a selected time period after a meal to keep glucose level in a predetermined range.
6 . The method of claim 1 , comprising providing customized coaching with the mobile device to the user to achieve the plan.
7 . The method of claim 1 , comprising adjusting via the mobile device a timing or intensity of a selected physical activity to maintain a glucose target.
8 . The method of claim 1 , comprising estimating a glucose level using bio-impedance sensors.
9 . The method of claim 1 , comprising measuring a user weight with a weight sensor and determining a weight loss program.
10 . The method of claim 1 , comprising measuring user activity or exercise with the mobile device and determining a weight loss program.
11 . The method of claim 1 , comprising determining via the mobile device user smoking or drug dependency and weaning the user from smoking or drug through a series of behavioral changes including exercise.
12 . The method of claim 1 , wherein the predetermined health condition comprises high blood pressure.
13 . The method of claim 1 , comprising cuff-less blood pressure sensing in a closed-loop feedback.
14 . The method of claim 1 , comprising upon detecting a blood pressure above a threshold, immediately reducing blood pressure with a diuretics, an angiotensin-converting enzyme (ACE) inhibitor, an angiotensin II receptor blocker (ARB), calcium channel blocker, alpha blocker, alpha-beta blocker, beta blocker, renin inhibitor, aldosterone antagonist, garlic, music therapy, biofeedback, deep breathing, or exercise.
15 . The method of claim 1 , comprising providing a biofeedback sensor to reduce blood pressure in real time.
16 . The method of claim 1 , comprising training a neural network with user data from the mobile device to model user states.
17 . The method of claim 16 , comprising performing with a remote computer distributed edge learning with differential privacy.
18 . The method of claim 1 , comprising social networking with people having selected user health characteristics.
19 . The method of claim 1 , wherein the coaching provides exercise feedback.
20 . The method of claim 1 , comprising using a wrist device with a deep penetrating optical beam to detect glucose from veins under a skin.Join the waitlist — get patent alerts
Track US2021233656A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.